Production-Ready AI in Pharma: What’s Working, What’s Not, and What’s Next
Complimentary refreshments and a networking reception will be served!
AI investment in pharma is surging — but production-grade results remain rare. According to MIT, 95% of enterprise GenAI pilots deliver zero measurable ROI. Meanwhile, fewer than 20% of organizations achieve strong returns, and only 12% of healthcare leaders consider today's AI reliable for clinical use. The gap between promise and reality is costing the industry billions.
Join Roche, CMC AI, and Celestial Systems for an intimate, invitation-only session in South San Francisco where senior pharma and biotech leaders will cut through the noise and get specific about what it actually takes to move AI from experimentation to production in regulated environments.
Three short presentations will cover:
Enterprise-grade AI in life sciences — why most pharma AI pilots fail to reach production, and how platform strategy changes the odds
AI-driven CMC process optimization — where AI is reshaping Chemistry, Manufacturing, and Controls, from formulation design to regulatory submissions
From AI strategy to production deployment — what it takes to bridge the gap between promising pilots and scalable, governed AI systems in regulated industries
A moderated Q&A will then dig deeper into these themes and open the floor to the room.
If you're working to make AI deliver real results in pharma or biotech — whether in R&D, operations, or strategy — this is a room worth being in. Expect a small group, candid conversation, and enough time to connect with peers before heading home for the evening.
Our Speakers
Alok Singh — Global AI Product Manager, Roche
Alok leads one of Roche's largest clinical data and content generation programs. He brings over 15 years of experience in AI and machine learning, with prior roles at Amazon and the San Diego Supercomputer Center. Alok speaks regularly at industry forums including AIMed and the America Drug Safety & AI Summit.
Sunil Shah, Ph.D., RAC — CEO & Co-Founder, CMC AI
Dr. Sunil Shah brings over 35 years of CMC experience across pharma and biotech, including 12 years at Pfizer. He co-founded CMC AI to build an AI-based platform for managing CMC processes more efficiently across the drug development lifecycle.
Rahul Raina — VP of Business Development, Celestial Systems
Rahul has spent over 15 years driving growth at Celestial Systems, helping Fortune 100 companies, mid-market firms, and startups navigate digital transformation through modern applications, data intelligence, and cloud-native infrastructure. As VP of Business Development, he leads the team responsible for identifying new opportunities, building strategic partnerships, and ensuring business development efforts are tightly aligned with Celestial's broader engineering and delivery capabilities.
Moderator: Shri Shrivas — Director, Informatics Product Management, Genentech
Shri drives innovation in therapeutic areas across the patient and provider journey at Genentech. He brings over 25 years of experience in healthcare IT, medical devices, and clinical systems, with prior leadership roles at CareFusion, TeraRecon, and Abbott.
The Venue
The session will be hosted at Hilton Garden Inn San Francisco Airport North — steps from the Genentech campus and directly across from the shuttle pickup at Poletti Way, making it easy for attendees to join on their way out for the day.
About Us
Genentech — A member of the Roche Group and a pioneer of the biotechnology industry since 1976, Genentech discovers, develops, manufactures, and commercializes medicines for serious and life-threatening diseases. Headquartered in South San Francisco, the company's breakthroughs include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. Learn more at gene.com.
Roche — One of the world's largest biotech companies and a pioneer in personalised medicine, Roche has been at the forefront of cancer research, diagnostics, and drug development for over 125 years. Headquartered in Basel, Switzerland, Roche operates one of its largest R&D hubs in South San Francisco. Learn more at roche.com.
CMC AI — Building an AI-based platform to streamline Chemistry, Manufacturing, and Controls (CMC) processes in pharmaceutical drug development. CMC AI brings deep domain expertise in CMC workflows, clinical supply chain, and regulatory considerations to help pharma and biotech companies reduce time and cost across the development lifecycle.
Celestial Systems — Founded in 2001, Celestial Systems combines a heritage of industry leadership in application engineering with deep expertise in AI solutions. With headquarters in Vancouver and a fully in-house engineering team, Celestial empowers organizations to leverage the power of AI in practical, responsible ways — unlocking new opportunities, reducing risk, and sharpening their competitive advantage.
Space is limited. This is an invite-only session for senior pharma and biotech leaders.